Thirty years ago, when I was a dermatology resident at Case Western Reserve, Cleveland, Drs George Binkley and Herbert Johnson used hyperthermia successfully for severe cases of psoriasis.Hospitalized patients were given two intravenous doses of killed typhoid bacilli at half-hour intervals; 10 to ...
MULTIPLE sclerosis treatmentINTRAVENOUS immunoglobulinsADRENOCORTICAL hormonesHORMONE therapyTHERAPEUTICSThe article presents a case study of a 30-year-old male with severe treatment-resistant erythrodermic psoriasis after intravenous immunoglobulin (IVIG) being given to treat multiple sclerosis (MS).Topics ...
Case studies in severe psoriasis: A clinical strategy Journal of Dermatological TreatmentLebwohl M, Menter A, Koo J, Feldman S. Case studies in severe psoriasis: a clinical strategy. J Dermatolog Treat. ... M Lebwohl,A Menter,J Koo,... - 《Journal of Dermatological Treatment》 被引量: ...
In case of psoriasis, biologics utilize molecules that are designed to block specific molecular steps, vital to the pathogenesis of psoriasis. The biologics used to treat psoriasis, block the action of a specific type of immune cell, called a T cell or block proteins like tumor necrosis factor-...
Severe psoriasis with positive tuberculosis test and treatment with biologic therapy: a case report Skroza N; Proietti I; Bemardini N;.Severe psoriasis with positivetuberculosis test and treatment with biologic therapy: case report.Cutis.2012.120-122... Cutis 被引量: 0发表: 0年 Tuberculosis ...
aSalcura Zeoderm has a proven track record and is one of our most effective and practical solutions for more severe cases of eczema, psoriasis, dermatitis and other related skin conditions. Salcura Zeoderm有一个证实的记录并且是我们的一种最有效和最实用的解答为湿疹、牛皮癣、皮炎和其他相关皮肤状况...
apopulation and estimated the attributable risk of severe psoriasis. 正在翻译,请等待... [translate] aBACKGROUND: Recent studies suggest that psoriasis, particularly if severe, may be a risk factor for major 背景: 最近研究建议那牛皮癣,特别如果严厉,也许是风险因素为少校 [translate] ...
psoriasis have a 53 percent increased incidence of MACE compared to the general population. They also found that having a diagnosed case of severe psoriasis confers an additional ten-year risk of 6 percent on MACE. The study results were reported at the 2011 American College of Cardiology ...
Ustekinumab was recently approved for the treatment of psoriasis in pediatric patients aged 12 and older, providing another on-label therapeutic option for adolescents.2, 3 In refractory cases, however, alternative treatment options often need to be pursued. Here we present a case of severe, recalc...
They also point out that, although the relative risk was higher in younger patients, the absolute risk of chronic kidney disease attributable to psoriasis increases with age. For example, in patients aged 40-50 with severe disease, psoriasis accounts for one extra case of chronic kidney disease ...